Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma

NCT01649856

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • EHS CAC Hospital FRANTZ FANON ZABANA BLIDA; Hematology ward Blida, Algeria
  • Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie Tizi Ouzou, Algeria
  • Cemic; Haematology Buenos Aires, Argentina
  • Hospital Privado de Comunidad; Oncology Mar del Plata, Argentina
View all 186 locations
View Trial Details
Completed

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

NCT00659425

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Memphis, Tennessee, United States
View Trial Details
Completed

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

NCT00309907

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +86 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Oncology Group Arcadia, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 26 locations
View Trial Details
Completed

Akt Inhibitor MK2206 in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT01481129

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hopitaux de Paris Vellefaux, Paris, France
  • Institut Bergonie Cancer Center Bordeaux, France
  • Henri Mondor University-Hospital Center Créteil, France
  • Hospital Claude Huriez Chru Lille, France
View Trial Details
Completed

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

NCT01399840

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +24 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
  • University of Wisconsin Madison, Wisconsin, United States
  • University College London London, United Kingdom
View Trial Details
Completed

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease

NCT00348140

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +17 more
Locations
  • GSK Investigational Site Sun City, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Laguna Hills, California, United States
View all 194 locations
View Trial Details

Related conditions